Trimeresurus albolabris snakebite treatment implications arising from ontogenetic venom comparisons of anticoagulant function, and antivenom efficacy.

MLA

Bourke, Lachlan A., et al. “Trimeresurus Albolabris Snakebite Treatment Implications Arising from Ontogenetic Venom Comparisons of Anticoagulant Function, and Antivenom Efficacy.” Toxicology Letters, vol. 327, July 2020, pp. 2–8. EBSCOhost, https://doi.org/10.1016/j.toxlet.2020.03.009.

APA

Bourke, L. A., Youngman, N. J., Zdenek, C. N., Op den Brouw, B., Violette, A., Fourmy, R., & Fry, B. G. (2020). Trimeresurus albolabris snakebite treatment implications arising from ontogenetic venom comparisons of anticoagulant function, and antivenom efficacy. Toxicology Letters, 327, 2–8. https://doi.org/10.1016/j.toxlet.2020.03.009

Chicago

Bourke, Lachlan A, Nicholas J Youngman, Christina N Zdenek, Bianca Op den Brouw, Aude Violette, Rudy Fourmy, and Bryan G Fry. 2020. “Trimeresurus Albolabris Snakebite Treatment Implications Arising from Ontogenetic Venom Comparisons of Anticoagulant Function, and Antivenom Efficacy.” Toxicology Letters 327 (July): 2–8. doi:10.1016/j.toxlet.2020.03.009.